Monte Rosa Therapeutics, Inc.
GLUE- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001826457
In the last 90 days, Monte Rosa Therapeutics, Inc. insiders filed 0 open-market purchases and 6 sales; 192 institutions reported holding it in 13F filings for Q2 2026, worth $2.24B in total; Duquesne Family Office is the only superinvestor holding it.
13F holders, Q3 2021
Institutional positions in Monte Rosa Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 56
- +8 vs. Q2 2021
- Shares held
- 34.9M
- +2.80M (+8.7%) vs. Q2 2021
- Total value
- $759.4M
- +$54.3M (+7.7%) vs. Q2 2021
- New holders
- 28
- 6 more added
- Sold out
- 20
- 13 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GLUE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 192 | $2.24B |
| Q1 2026 | 191 | $1.43B |
| Q4 2025 | 161 | $1.01B |
| Q3 2025 | 129 | $444.9M |
| Q2 2025 | 116 | $280.6M |
| Q1 2025 | 106 | $276.2M |
| Q4 2024 | 105 | $423.3M |
| Q3 2024 | 81 | $263.7M |
| Q2 2024 | 75 | $171.7M |
| Q1 2024 | 68 | $281.3M |
| Q4 2023 | 71 | $226.6M |
| Q3 2023 | 71 | $201.4M |
| Q2 2023 | 68 | $272.3M |
| Q1 2023 | 69 | $309.8M |
| Q4 2022 | 66 | $313.8M |
| Q3 2022 | 70 | $328.8M |
| Q2 2022 | 57 | $375.0M |
| Q1 2022 | 52 | $559.9M |
| Q4 2021 | 53 | $742.0M |
| Q3 2021 | 56 | $759.4M |
| Q2 2021 | 48 | $705.1M |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Monte Rosa Therapeutics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| NEA Management Company, LLC | 7,703,205 | $171.6M | 2.15% | 00.0% | Unchanged |
| FMR LLC | 6,957,284 | $152.9M | 0.01% | +2,645,025+61.3% | Added |
| Price T Rowe Associates Inc | 3,146,934 | $69.3M | 0.01% | +409,280+15.0% | Added |
| Cormorant Asset Management, LP | 3,102,199 | $68.0M | 2.76% | −91,774−2.9% | Reduced |
| Avoro Capital Advisors LLC | 3,311,434 | $61.0M | 0.96% | 00.0% | Unchanged |
| BlackRock Inc. | 2,068,677 | $46.1M | 0.00% | +518,792+33.5% | Added |
| Aisling Capital Management LP | 1,472,331 | $32.8M | 6.54% | 00.0% | Unchanged |
| Alphabet Inc. | 1,464,015 | $32.6M | 0.77% | 00.0% | Unchanged |
| RTW Investments, LP | 1,214,572 | $26.0M | 0.39% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,020,021 | $22.7M | 0.00% | +920,021+920.0% | Added |
| Casdin Capital, LLC | 960,883 | $21.4M | 0.53% | 00.0% | Unchanged |
| Avidity Partners Management LP | 300,000 | $6.68M | 0.17% | 00.0% | Unchanged |
| Jennison Associates LLC | 296,379 | $6.60M | 0.00% | −3,621−1.2% | Reduced |
| Geode Capital Management, LLC | 195,783 | $4.36M | 0.00% | +195,783 | New |
| Millennium Management LLC | 175,445 | $3.91M | 0.01% | −59,657−25.4% | Reduced |
| State Street Corp | 151,542 | $3.38M | 0.00% | +151,542 | New |
| Octagon Capital Advisors LP | 150,000 | $3.34M | 0.82% | −88,045−37.0% | Reduced |
| Woodline Partners LP | 134,033 | $2.99M | 0.05% | −74,035−35.6% | Reduced |
| Sphera Funds Management Ltd. | 119,647 | $2.67M | 0.26% | +19,647+19.6% | Added |
| Northern Trust Corp | 103,997 | $2.32M | 0.00% | +103,997 | New |
| Voya Investment Management LLC | 102,821 | $2.29M | 0.00% | −1,356−1.3% | Reduced |
| Morgan Stanley | 93,901 | $2.09M | 0.00% | +93,901 | New |
| Alliancebernstein L.P. | 84,447 | $1.88M | 0.00% | −54,648−39.3% | Reduced |
| Charles Schwab Investment Management Inc | 79,974 | $1.78M | 0.00% | +79,974 | New |
| Bank of America Corp | 79,501 | $1.77M | 0.00% | +79,501 | New |
| Logos Global Management LP | 50,000 | $1.11M | 0.08% | −250,000−83.3% | Reduced |
| Caas Capital Management LP | 50,000 | $1.11M | 0.08% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 47,124 | $1.05M | 0.00% | +47,124 | New |
| TD Asset Management Inc | 38,764 | $864.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 37,549 | $836.0K | 0.00% | −58,243−60.8% | Reduced |
| Bank of New York Mellon Corp | 27,856 | $621.0K | 0.00% | +27,856 | New |
| Soleus Capital Management, L.P. | 25,000 | $557.0K | 0.09% | −50,000−66.7% | Reduced |
| Goldman Sachs Group Inc | 19,119 | $426.0K | 0.00% | −89,381−82.4% | Reduced |
| Nuveen Asset Management, LLC | 16,754 | $373.0K | 0.00% | +16,754 | New |
| Ghisallo Capital Management LLC | 15,000 | $334.0K | 0.01% | −5,000−25.0% | Reduced |
| Cubist Systematic Strategies, LLC | 10,731 | $239.0K | 0.00% | +10,731 | New |
| Rhumbline Advisers | 9,233 | $206.0K | 0.00% | +9,233 | New |
| Deutsche Bank AG | 7,698 | $171.0K | 0.00% | +7,698 | New |
| SG Americas Securities, LLC | 7,238 | $161.0K | 0.00% | +7,238 | New |
| American International Group, Inc. | 6,333 | $141.0K | 0.00% | +6,333 | New |
| California State Teachers Retirement System | 6,252 | $139.0K | 0.00% | +6,252 | New |
| MetLife Investment Management | 4,756 | $106.0K | 0.00% | +4,756 | New |
| JPMorgan Chase & Co | 4,432 | $99.0K | 0.00% | +4,432 | New |
| New York State Common Retirement Fund | 4,100 | $91.0K | 0.00% | +4,100 | New |
| Metropolitan Life Insurance Co | 3,598 | $80.2K | 0.00% | +3,598 | New |
| STRS Ohio | 2,700 | $60.0K | 0.00% | +2,700 | New |
| Piper Sandler & Co. | 2,300 | $51.0K | 0.07% | +2,300 | New |
| Tower Research Capital LLC (TRC) | 1,385 | $31.0K | 0.00% | +985+246.3% | Added |
| Citigroup Inc | 1,321 | $29.0K | 0.00% | +1,321 | New |
| Royal Bank of Canada | 1,279 | $29.0K | 0.00% | +1,279 | New |
| Legal & General Group Plc | 1,082 | $24.0K | 0.00% | −1,918−63.9% | Reduced |
| Ameritas Investment Partners, Inc. | 887 | $20.0K | 0.00% | +887 | New |
| Northwestern Mutual Wealth Management Co | 300 | $7.00K | 0.00% | +300 | New |
| Migdal Insurance & Financial Holdings Ltd. | 250 | $6.00K | 0.00% | +250 | New |
| Wells Fargo & Company | 57 | $1.00K | 0.00% | +57 | New |
| Berman Capital Advisors, LLC | 40 | $0 | 0.00% | +40 | New |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −350,000−100.0% | Sold out |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −350,000−100.0% | Sold out |
| Suvretta Capital Management, LLC | 0 | $0 | 0.00% | −150,000−100.0% | Sold out |
| Sectoral Asset Management Inc | 0 | $0 | 0.00% | −129,633−100.0% | Sold out |
| Ratan Capital Management LP | 0 | $0 | 0.00% | −120,000−100.0% | Sold out |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −120,000−100.0% | Sold out |
| HealthCor Management, L.P. | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Pura Vida Investments, LLC | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −58,500−100.0% | Sold out |
| Hound Partners, LLC | 0 | $0 | 0.00% | −49,995−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Pinz Capital Management, LP | 0 | $0 | 0.00% | −43,700−100.0% | Sold out |
| Norges Bank | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −28,209−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −13,100−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −10,606−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −11,106−100.0% | Sold out |
| Wellington Management Group LLP | 0 | $0 | 0.00% | −9,192−100.0% | Sold out |